Moderna, Inc. (MRNA) Gross margin 2018–2025
Moderna, Inc. (MRNA) gross margin by fiscal year — reported gross profit divided by reported revenue.
55.3%FY2025 · since FY2018: 100.0% → 55.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 55.3% | +0.6 pp |
| FY2024 | 54.8% | +23.3 pp |
| FY2023 | 31.5% | -40.4 pp |
| FY2022 | 71.9% | -13.9 pp |
| FY2021 | 85.8% | -13.2 pp |
| FY2020 | 99.0% | -1.0 pp |
| FY2019 | 100.0% | +0.0 pp |
| FY2018 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice